REATA PHARMACEUTICALS INC Proceeds from Long-Term Debt Issued
REATA PHARMACEUTICALS INC reported Proceeds from Long-Term Debt Issued of $72.56 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2023-08-08
- REATA PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $0.00.
- REATA PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2018-09-30 was $0.00.
- REATA PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2017-12-31 was $0.00.
- REATA PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2017-09-30 was $0.00.
- REATA PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2019 was $75.00M, a 25.00% increase from fiscal 2018.
- REATA PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2018 was $60.00M, a 200.00% increase from fiscal 2017.
- REATA PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2017 was $20.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 3 month as first filed | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $72.56M 10-Q · filed 2023-08-08 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | ||||
| 2019-12-31 | $75.00M 10-K · filed 2020-02-19 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $0.00 derived: sum of 2 quarters · filed 2020-02-19 | $60.00M 10-K · filed 2020-02-19 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $60.00M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $60.00M 10-Q · filed 2019-08-08 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $0.00 derived: sum of 2 quarters · filed 2020-02-19 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | $20.00M 10-K · filed 2020-02-19 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $20.00M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $20.00M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | $20.00M 10-Q · filed 2018-05-08 | $19.84M 10-Q · filed 2017-05-10 |